WALTHAM, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. DYN, a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to present at the following investor conferences in November: A live webcast of each…Read More
Dyne Therapeutics to Present at November Investor Conferences Dyne Therapeutics NASDAQDYN
